Zhejiang Hisun Biomaterials Co.Ltd. (SHA:688203)
China · Delayed Price · Currency is CNY 13.01
-0.02 (-0.15%)
Apr 28, 2026, 4:00 PM EDT
SHA:688203 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 10.68 | 9.87 | 35.5 | 43.55 | 47.04 | 35.27 |
Depreciation & Amortization | 70.01 | 70.01 | 65.5 | 54.68 | 42.88 | 37.06 |
Other Amortization | 0.08 | 0.08 | - | - | - | - |
Loss (Gain) From Sale of Assets | 0.01 | 0.01 | -0.03 | - | -5.13 | 0.62 |
Asset Writedown & Restructuring Costs | 2.12 | 2.12 | 0.54 | 0.97 | 0.01 | 0.3 |
Loss (Gain) From Sale of Investments | -2.33 | -2.33 | - | -0.27 | 1.09 | -0.19 |
Provision & Write-off of Bad Debts | -0.32 | -0.32 | 1.51 | 0.89 | 0.33 | - |
Other Operating Activities | -21.48 | 5.04 | 9.03 | 5.68 | 2.99 | 12.07 |
Change in Accounts Receivable | -45.42 | -45.42 | -85.65 | -66.57 | -33.19 | -2.06 |
Change in Inventory | -32.93 | -32.93 | -18.48 | -9.81 | -15.16 | -48.45 |
Change in Accounts Payable | 14.2 | 14.2 | 32.44 | 134.52 | 95.34 | 36.58 |
Operating Cash Flow | -4.87 | 20.84 | 38.84 | 163.03 | 136.15 | 71.18 |
Operating Cash Flow Growth | - | -46.33% | -76.18% | 19.75% | 91.27% | 148.37% |
Capital Expenditures | -99.79 | -127.16 | -293.18 | -214.11 | -225.27 | -309.44 |
Sale of Property, Plant & Equipment | 0.03 | 0 | - | - | 78.43 | 0.04 |
Investment in Securities | - | - | - | - | 42 | -42 |
Other Investing Activities | -51.74 | -52 | - | 0.31 | -0.22 | -0.33 |
Investing Cash Flow | -151.51 | -179.16 | -293.18 | -213.8 | -105.07 | -351.72 |
Long-Term Debt Issued | - | 194.76 | 114.1 | 136.41 | 178.07 | 315.24 |
Short-Term Debt Repaid | - | -7.91 | -4.93 | - | - | - |
Long-Term Debt Repaid | - | -181.72 | -180.73 | -151.24 | -292.88 | -357.2 |
Total Debt Repaid | -212.86 | -189.62 | -185.66 | -151.24 | -292.88 | -357.2 |
Net Debt Issued (Repaid) | -23.21 | 5.13 | -71.56 | -14.83 | -114.8 | -41.96 |
Issuance of Common Stock | - | - | - | - | 778.33 | - |
Repurchase of Common Stock | -12.24 | -12.24 | -9 | - | - | - |
Common Dividends Paid | -17.55 | -18.15 | -23.59 | -23.33 | -15.83 | -14.44 |
Other Financing Activities | -1.22 | - | 12.84 | - | -14.1 | -10.1 |
Financing Cash Flow | -54.21 | -25.26 | -91.31 | -38.16 | 633.6 | -66.51 |
Foreign Exchange Rate Adjustments | -0.92 | -0 | 2.12 | 1.78 | 7.93 | -1.34 |
Net Cash Flow | -211.51 | -183.58 | -343.53 | -87.15 | 672.6 | -348.39 |
Free Cash Flow | -104.66 | -106.32 | -254.34 | -51.08 | -89.13 | -238.26 |
Free Cash Flow Margin | -11.45% | -12.48% | -30.09% | -6.78% | -14.72% | -40.73% |
Free Cash Flow Per Share | -0.52 | -0.53 | -1.29 | -0.25 | -0.53 | -1.55 |
Cash Income Tax Paid | 32.37 | 34.04 | 9.47 | 21.44 | -13.11 | -20.84 |
Levered Free Cash Flow | -120.75 | -141.3 | -231.09 | -96.56 | -153.45 | -423.21 |
Unlevered Free Cash Flow | -116.95 | -137.5 | -226.35 | -91.88 | -147.43 | -416.48 |
Change in Working Capital | -63.63 | -63.63 | -73.22 | 57.53 | 46.94 | -13.95 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.